New Targeted Therapies in Breast Cancer

Chand, Ashwini (Primary Chief Investigator (PCI))

Hudson Institute - Centre for Reproductive Health

Prince Henry's Institute of Medical Research

Project: Research

Status	Finished
Effective start/end date	1/01/14 → 31/12/17

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$404,884.00

1 Article

The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma
Coulson, R., Liew, S. H., Connelly, A. A., Yee, N. S., Deb, S., Kumar, B., Vargas, A. C., O'Toole, S. A., Parslow, A. C., Poh, A., Putoczki, T., Morrow, R. J., Alorro, M., Lazarus, K. A., Yeap, E. F. W., Walton, K. L., Harrison, C. A., Hannan, N. J., George, A. J., Clyne, C. D., & 3 othersErnst, M., Allen, A. M. & Chand, A. L., 20 Feb 2017, In: Oncotarget. 8, 12, p. 18640-18656 17 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

47 Citations (Scopus)